Arrowstreet Capital’s Royalty Pharma RPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $116M | Buy |
|
|||||
|
2025
Q2 | $107M | Buy |
|
|||||
|
2025
Q1 | $42.4M | Buy |
|
|||||
|
2024
Q4 | $17.1M | Sell |
|
|||||
|
2024
Q3 | $39.3M | Buy |
|
|||||
|
2024
Q2 | $24.8M | Buy |
|
|||||
|
2024
Q1 | $26.8M | Sell |
|
|||||
|
2023
Q4 | $50M | Sell |
|
|||||
|
2023
Q3 | $53M | Buy |
|
|||||
|
2023
Q2 | $58.8M | Sell |
|
|||||
|
2023
Q1 | $70.5M | Sell |
|
|||||
|
2022
Q4 | $98.8M | Buy |
|
|||||
|
2022
Q3 | $77.2M | Buy |
|
|||||
|
2022
Q2 | $44.4M | Buy |
|
|||||
|
2022
Q1 | $23.1M | Buy |
|
|||||
|
2021
Q4 | – | Sell |
|
|||||
|
2021
Q3 | $2.14M | Buy |
|
|||||
|
2021
Q2 | – | Sell |
|
|||||
|
2021
Q1 | $781K | Buy |
|
|||||
|
2020
Q4 | – | Sell |
|
|||||
|
2020
Q3 | $12.4M | Buy |
|